XERS

NASDAQ 已收盘

Xeris Biopharma Holdings

16.62 USD
▼-0.37-2.18%
盘后 16.67 +0.30%
2026-11-19
市值
$3.10B
市盈率
126.52
EPS
-0.04
股息率
—
52 周区间
5.25 – 17.28
成交量
2.57M
Beta
0.84
目标价
17.29
52W 低 5.2552W 高 17.28
价格走势

公司简介

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patient...

关联新闻